ScreenerHero
DIADiaSorin S.p.A.
BIT · IT · Healthcare · Diagnostics & Research · int.diasorin.com
74.22EUR-0.67%Mkt Cap: 4.02B $P/E: 27.47

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiag…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap4.02B $
Enterprise Value4.88B $
Revenue (TTM)1.28B $
Gross Profit840.73M $
Net Income (TTM)169.16M $
Revenue/Share24.98 USD
Last Price74.22 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.3K
CountryIT
SectorHealthcare
IndustryDiagnostics & Research
ISINIT0003492391
Valuation
P/E (Trailing)27.47
P/E (Forward)17.19
PEG1.74
EV/EBITDA13.07
EV/Revenue3.81
P/S3.10
P/B2.56
EPS (TTM)2.72
EPS (Forward)4.29
52W Range
52.3455% of range92.32
52W High92.32 EUR
52W Low52.34 EUR
Profitability
Gross Margin64.72%
Oper. Margin22.21%
EBITDA Margin29.14%
Profit Margin13.02%
ROE9.82%
ROA5.42%
Growth
Revenue Growth2.70%
Earnings Growth6.60%
Cash Flow & Leverage
Operating CF372.57M $
CapEx (TTM)149.65M $
FCF Margin11.34%
FCF Yield3.61%
Net Debt917.80M $
Net Debt/EBITDA2.46
Balance Sheet
Debt/Equity0.50
Current Ratio1.79
Quick Ratio0.85
Book Value/Sh28.76 EUR
Cash/Share2.442 EUR
Dividends
Fwd Div Rate1.300 EUR
Trail. Div Rate1.300 EUR
Div. Yield1.74%
5Y Avg Yield1.16%
Payout Ratio47.79%
Ex-Div DateMay 18, 2026
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)71.66 EUR
Upside (mean)-3.4%
Target Range55.00 EUR – 90.00 EUR
€55.00-3.4% to mean€90.00
# Analysts14
Ownership
Shares Out.49.44M
Float14.96M
Insiders57.56%
Institutions14.30%
Technical
SMA 5069.66 (+6.5%)
SMA 20066.87 (+11.0%)
Beta0.69
S&P 52W Chg19.97%
Avg Vol (30d)224.16K
Avg Vol (10d)168.02K
Technical Indicators
RSI (14)59.2
MACD1.4833
MACD Signal1.6159
MACD Hist.-0.1326
BB Upper79.10 EUR
BB Middle72.76 EUR
BB Lower66.43 EUR
BB Width17.41%
ATR (14)1.865 EUR
Vol Ratio (20d)0.63x